Innovation in European healthcare – what can Sweden learn? - LIF

The Medical Research Council (MRC) is a public organisation
supporting world-class research across a spectrum of medical
sciences
• The MRC works closely with key stakeholders like other UK research funders and organsiations, UK health
departments, six other research councils, the Technology Strategy Board, industry, academia, and charity
sectors.
• The MRC is committed to translational research and works closely with NIHR and other bodies to ensure
there are integrated funding schemes and the needed infrastructure and facilities.
• The MRC leads translational research on themes of experimental medicine, methodology and
regenerative medicine, whereas the NIHR leads on clinical evaluations and trials.
• The MRC prioritses partnerships and collaborations with industry and other public bodies to accelerate the
commercialisation of laboratory research to products and interventions that add value to the economy and
standard patient care.
• In 2011/12 the MRC’s gross research expenditure was £768.8m (compared with £797.7m in 2010/11). This
included:
• £309.9m on 1,100 grants to researchers in universities, medical schools, and research institutions.
• £354.6m on 440 programmes within the MRCs own research, units and institutes.
• £86.0m on studentships and fellowships, including those in MRC’s own units and institutes.
• £18.3m for international subscriptions.
196